Lanean...
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
BACKGROUND: For patients with axillary lymph node-negative breast cancer, benefits from adjuvant therapy are smaller than in node-positive disease and thus more selective use is warranted, prompting development of risk profiling to identify those most likely to benefit. Examination of the magnitude...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2008
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2711214/ https://ncbi.nlm.nih.gov/pubmed/18830816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-008-0200-5 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|